Jeffrey D. Capello
Chief Financial Officer, Revvity Inc.
Companies
- Agios PharmaceuticalsBoard member Jun 15, 2023 to now1
- NeoGenBoard member Sep 12, 2022 to now2
- BiogenChief financial officer Dec 18, 2017 to Feb 14, 20203
- Tempest Therapeutics, Inc.Board member Jun 11, 2012 to Jul 6, 20184
- Decoy Therapeutics Inc.Board member Apr 10, 2015 to Jul 27, 20175
- Boston ScientificChief financial officer Jun 18, 2010 to Dec 2, 20136
- Boston ScientificChief Accounting Officer Jun 18, 2008 to Mar 2, 20107
- Revvity Inc.Chief financial officer Feb 2, 2006 to Jan 31, 20088
- Revvity Inc.Chief Accounting Officer Oct 24, 2003 to Nov 2, 20059
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Revvity Inc. RVTY91,428 shares10$13.9M at $152.28Jan 29, 2008
NeoGen NEOG32,502 shares11$379.1K at $11.66Oct 27, 2025
Agios Pharmaceuticals AGIO10,865 shares12$373.3K at $34.36Jun 18, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 18, 2026Exercised options 2,816 shares of Agios Pharmaceuticals12
- Jun 13, 2026Exercised options 1,976 shares of Agios Pharmaceuticals13
- Oct 27, 2025Exercised options 1,777 shares at $6.19 of NeoGen11
- Oct 27, 2025Exercised options 2,025 shares at $6.19 of NeoGen14
- Oct 23, 2025Granted 19,769 shares at $6.07 of NeoGen15
- Oct 7, 2025Exercised options 2,071 shares at $5.63 of NeoGen16
- Jun 20, 2025Exercised options 2,120 shares of Agios Pharmaceuticals17
- Jun 13, 2025Exercised options 1,977 shares of Agios Pharmaceuticals18
- Apr 22, 2025Bought 20,712 shares at $4.84 of NeoGen19
- Oct 28, 2024Exercised options 1,776 shares at $13.81 of NeoGen20
- Oct 24, 2024Granted 6,075 shares at $13.58 of NeoGen21
- Oct 7, 2024Exercised options 2,070 shares at $15.07 of NeoGen22
- Jun 13, 2024Exercised options 1,976 shares of Agios Pharmaceuticals23
- Jan 29, 2008Granted 17,699 shares of Revvity Inc.10
- May 31, 2007Sold 10,000 shares at $26.39 of Revvity Inc.24
- May 31, 2007Sold 27,200 shares at $26.40 of Revvity Inc.24
- May 31, 2007Sold 100 shares at $26.42 of Revvity Inc.24
- May 31, 2007Sold 200 shares at $26.41 of Revvity Inc.24
- May 31, 2007Exercised options 37,500 shares at $8.16 of Revvity Inc.24
- Jan 30, 2007Granted 18,893 shares of Revvity Inc.25
- Jan 24, 2007Returned to company 3,334 shares of Revvity Inc.26
- Jan 31, 2006Granted 20,226 shares of Revvity Inc.27
- Oct 31, 2005Sold 16,667 shares at $22.00 of Revvity Inc.28
- Oct 31, 2005Exercised options 16,667 shares at $12.22 of Revvity Inc.28
- Jan 25, 2005Granted 17,321 shares at $21.02 of Revvity Inc.29
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAgios Pharmaceuticals, Board member
- 2SEC EDGARNeoGen, Board member
- 3SEC EDGARBiogen, Chief financial officer
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARForm 4 filed Jun 16, 2026
- 14SEC EDGARForm 4 filed Oct 28, 2025
- 15SEC EDGARForm 4 filed Oct 27, 2025
- 16SEC EDGARForm 4 filed Oct 9, 2025
- 17SEC EDGARForm 4 filed Jun 23, 2025
- 18SEC EDGARForm 4 filed Jun 17, 2025
- 19SEC EDGARForm 4 filed Apr 22, 2025
- 20SEC EDGARForm 4 filed Oct 29, 2024
- 21SEC EDGARForm 4 filed Oct 28, 2024
- 22SEC EDGARForm 4 filed Oct 9, 2024
- 23SEC EDGARForm 4 filed Jun 17, 2024
- 24SEC EDGARForm 4 filed Jun 1, 2007
- 25SEC EDGARForm 4 filed Feb 1, 2007
- 26SEC EDGARForm 4 filed Jan 26, 2007
- 27SEC EDGARForm 4 filed Feb 2, 2006
- 28SEC EDGARForm 4 filed Nov 2, 2005
- 29SEC EDGARForm 4 filed Jan 27, 2005